Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model
暂无分享,去创建一个
M. Sanson | A. Petiet | A. Idbaih | M. Verreault | N. Zahr | C. Schmitt | G. Bouchoux | M. Santin | M. Canney | C. Guerin | A. Carpentier | I. Hernández-Verdin | N. Lemaire | Mohammed H. Ahmed | Lea Guyonnet | E. Quissac | Coralie Guerin | Laura Mouton | M. Ahmed
[1] F. Degertekin,et al. Spatially targeted brain cancer immunotherapy with closed-loop controlled focused ultrasound and immune checkpoint blockade , 2022, Science advances.
[2] Mark W. Youngblood,et al. Ultrasound-mediated blood–brain barrier opening increases cell-free DNA in a time-dependent manner , 2021, Neuro-oncology advances.
[3] K. Hynynen,et al. MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases , 2021, Science Translational Medicine.
[4] Santiago J. Carmona,et al. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting , 2021, Cell reports. Medicine.
[5] J. Rubin,et al. Focused Ultrasound-Enhanced Delivery of Intranasally Administered Anti-Programmed Cell Death-Ligand 1 Antibody to an Intracranial Murine Glioma Model , 2021, Pharmaceutics.
[6] I. Obeso,et al. Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease. , 2020, The New England journal of medicine.
[7] I. Parhar,et al. Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma , 2020, Molecules.
[8] B. Neyns,et al. Axitinib plus avelumab in the treatment of recurrent glioblastoma: a stratified, open-label, single-center phase 2 clinical trial (GliAvAx) , 2020, Journal for ImmunoTherapy of Cancer.
[9] W. Jiang,et al. PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis , 2020, Frontiers in Oncology.
[10] M. Weller,et al. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma , 2020, JAMA oncology.
[11] X. Breakefield,et al. Glioblastoma hijacks microglial gene expression to support tumor growth , 2020, Journal of Neuroinflammation.
[12] A. Rezai,et al. Noninvasive hippocampal blood−brain barrier opening in Alzheimer’s disease with focused ultrasound , 2020, Proceedings of the National Academy of Sciences.
[13] P. French,et al. Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives , 2020, Cancers.
[14] J. Grill,et al. Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors. , 2020, Cancer letters.
[15] B. Becher,et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas , 2020, Nature Communications.
[16] Cao Xie,et al. Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[17] C. James,et al. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations , 2019, Clinical Cancer Research.
[18] Lixia Xu,et al. Enhanced Expression of PD-L1 on Microglia After Surgical Brain Injury Exerts Self-Protection from Inflammation and Promotes Neurological Repair , 2019, Neurochemical Research.
[19] J. Frank,et al. In vivo imaging of sterile microglial activation in rat brain after disrupting the blood-brain barrier with pulsed focused ultrasound: [18F]DPA-714 PET study , 2019, Journal of Neuroinflammation.
[20] M. Sanson,et al. Temporary blood–brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma , 2019, Journal of Neuro-Oncology.
[21] Arthur André,et al. Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma , 2019, Clinical Cancer Research.
[22] E. Mardis,et al. Comprehensive gene expression meta-analysis identifies signature genes that distinguish microglia from peripheral monocytes/macrophages in health and glioma , 2019, Acta Neuropathologica Communications.
[23] A. Yonezawa,et al. Application of nSMOL coupled with LC‐MS bioanalysis for monitoring the Fc‐fusion biopharmaceuticals Etanercept and Abatacept in human serum , 2018, Pharmacology research & perspectives.
[24] E. Leuthardt,et al. Focused Ultrasound-enabled Brain Tumor Liquid Biopsy , 2018, Scientific Reports.
[25] A. Quiñones‐Hinojosa,et al. Advances in Brain Tumor Surgery for Glioblastoma in Adults , 2017, Brain sciences.
[26] K. Ligon,et al. Glioblastoma targeted therapy: updated approaches from recent biological insights , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[27] Yunhong Li,et al. Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60 , 2017, Molecular medicine reports.
[28] M. Weller,et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. , 2017, The Lancet. Oncology.
[29] S. Mériaux,et al. New in vivo avatars of diffuse intrinsic pontine gliomas (DIPG) from stereotactic biopsies performed at diagnosis. , 2017, Oncotarget.
[30] Rakesh K. Jain,et al. New Directions in Anti-Angiogenic Therapy for Glioblastoma , 2017, Neurotherapeutics.
[31] A. Idbaih,et al. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma , 2016, Expert review of neurotherapeutics.
[32] K. Hoang-Xuan,et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound , 2016, Science Translational Medicine.
[33] J. Kuo,et al. Focused Ultrasound Enhances Central Nervous System Delivery of Bevacizumab for Malignant Glioma Treatment. , 2016, Radiology.
[34] Kristen L. Jones,et al. Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model , 2015, Cancer Immunology Research.
[35] V. Shukla,et al. Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety. , 2015, Current cancer drug targets.
[36] J. Barnholtz-Sloan,et al. The epidemiology of glioma in adults: a "state of the science" review. , 2014, Neuro-oncology.
[37] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[38] S. Gautam,et al. The natural history of extracranial metastasis from glioblastoma multiforme , 2011, Journal of Neuro-Oncology.
[39] K. Hynynen,et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. , 2004, Ultrasound in medicine & biology.